Y chromosome linked UTY modulates sex differences in valvular fibroblast methylation in response to nanoscale extracellular matrix cues.
Rayyan M GorashiTalia BaddourSarah J ChittleNicole E Félix VélezMichaela A WenningLivia S A PassosLuisa MestroniDaewon ParkPeng GuoKristi S AnsethPublished in: bioRxiv : the preprint server for biology (2024)
Aortic valve stenosis (AVS) is a progressive disease wherein males develop valve calcification relative to females that develop valve fibrosis. Valvular interstitial cells (VICs) aberrantly activate to myofibroblasts during AVS, driving the fibrotic valve phenotype in females. Myofibroblasts further differentiate into osteoblast-like cells and secrete calcium nanoparticles, driving valve calcification in males. We hypothesized the lysine demethylase UTY (ubiquitously transcribed tetratricopeptide repeat containing, Y-linked) decreases methylation uniquely in response to nanoparticle cues in the valve extracellular matrix to promote an osteoblast-like phenotype. Here, we describe a bioinspired hydrogel cell culture platform to interrogate how nanoscale cues modulate sex-specific methylation states in VICs activating to myofibroblasts and osteoblast-like cells. We found UTY (ubiquitously transcribed tetratricopeptide repeat containing, Y-linked) modulates VIC phenotypes in response to nanoscale cues uniquely in males. Overall, we reveal a novel role of UTY in the regulation of calcification processes in males during AVS progression.
Keyphrases
- aortic valve
- extracellular matrix
- transcatheter aortic valve replacement
- aortic stenosis
- transcatheter aortic valve implantation
- aortic valve replacement
- genome wide
- chronic kidney disease
- dna methylation
- mitral valve
- atomic force microscopy
- induced apoptosis
- multiple sclerosis
- drug delivery
- signaling pathway
- high throughput
- systemic sclerosis
- coronary artery disease
- cell death
- cell cycle arrest